As of November 27, CRISPR Therapeutics AG (NASDAQ:CRSP) has a moderately positive opinion, with 60% analysts covering it having a Buy or equivalent rating. With a consensus 1-year median price target ...
On Nov. 25, Wood’s Ark funds bought 174,293 Alphabet (GOOG) Class C stock, valued at approximately $55.77 million. On the day ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback